Evidence map›Paper›PMID 30790096›Full record

ArticleCellular and molecular neurobiology2019

The MicroRNA Expression Profiles of Human Temporal Lobe Epilepsy in HS ILAE Type 1.

Chongyang Tang, Haiyang Wang, Hongmei Wu, Shi Yan, Zhibin Han, Zhenfeng Jiang, Meng Na, Mian Guo, Dunyue Lu, Zhiguo Lin

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular neurobiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Chongyang TangDepartment of Neurosurgery, The First Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, 150001, People's Republic of China.
Haiyang WangDepartment of Neurosurgery, The First Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, 150001, People's Republic of China.
Hongmei WuDepartment of Pathology, The Fourth Affiliated Hospital, Harbin Medical University, Harbin, People's Republic of China.
Shi YanDepartment of Neurosurgery, The First Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, 150001, People's Republic of China.
Zhibin HanDepartment of Neurosurgery, The First Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, 150001, People's Republic of China.
Zhenfeng JiangDepartment of Neurosurgery, The First Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, 150001, People's Republic of China.
Meng NaDepartment of Neurosurgery, The First Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, 150001, People's Republic of China.
Mian GuoDepartment of Neurosurgery, the Second Affiliated Hospital, Harbin Medical University, Harbin, People's Republic of China.
Dunyue LuDepartment of Neurosurgery, The First Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, 150001, People's Republic of China.
Zhiguo LinDepartment of Neurosurgery, The First Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, 150001, People's Republic of China. zhiguolin@outlook.com.
First Affiliated Hospital of Harbin Medical University · CNHarbin Medical University · CNFourth Affiliated Hospital of Harbin Medical University · CNSecond Affiliated Hospital of Harbin Medical University · CN

Funding

Foundation of Heilongjiang Health and Family Planning Commission 2018375Heilongjiang Provincial Postdoctoral Science Foundation LBH-Z17144National Natural Science Foundation of China 81571646National Natural Science Foundation of China 81572472National Natural Science Foundation of China 81601130National Natural Science Foundation of China 81772678National Natural Science Foundation of China 81773161Postdoctoral Science Foundation of China 2018M631951
6 · The paper itself

Abstract

Temporal lobe epilepsy (TLE) is associated with neurodegeneration, often leading to hippocampal sclerosis (HS). Type 1 HS, which is characterized by severe neuronal loss and gliosis predominantly in regions CA1 and CA4, is the most common subtype and is associated with the best prognosis according to the ILAE classification system. MiRNAs participate in the biological processes underlying many nervous system diseases, including epilepsy. However, the miRNA expression profile of HS ILAE type 1 is not completely understood. A total of 14 patients were identified as having the ILAE subtype, as determined by NeuN immunohistochemistry (ILAE type 1 = 7; no-HS = 7). Next-generation sequencing and reverse transcription polymerase chain reaction technology were used to validate the dysregulated miRNAs. Bioinformatics analysis of the predicted target genes was conducted using Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses. In total, 1643 mature miRNAs were detected in this study, along with 5 miRNAs that were upregulated and 2 miRNAs that were downregulated in the type 1 group. Bioinformatics analysis showed that 1545 target genes were predicted using the miRDB and Targetscan databases and that these predicted genes showed enrichment in pathways associated with nucleic acid binding, intracellular and cellular macromolecule metabolic processes, and the PI3K-Akt signaling pathway. This study is the first to report the miRNA expression profile of HS ILAE type 1 compared with those of no-HS. These results provide new insights into the neuronal loss pathology of type 1 HS.

Indexed as

Gene Expression ProfilingAdolescentAdultCase-Control StudiesChildComputational BiologyEpilepsy, Temporal LobeFemaleHippocampusHumansMaleMicroRNAsReproducibility of ResultsSclerosisYoung AdultMicroRNAsHS ILAE classificationMiRNA profilingNext-generation sequencingTarget predictionTLE

Identifiers

PMID30790096
PMCPMC11469846
OpenAlexW2917668897

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.